🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the abuse potential and safety of ...
Status
Completed
Location
Alkermes Investigational Site
Start Date
2014-08
Trial ID
NCT02218021
Treatments Being Tested
This study will evaluate the efficacy of ALKS 5461 when administered daily ...
Status
Completed
Location
Alkermes Investigational Site
Start Date
2011-12
Trial ID
NCT01500200
This is a Phase 3 study designed to evaluate the safety and tolerability of...
Status
Completed
Location
Alkermes Investigational Site
Start Date
2014-02
Trial ID
NCT02085135
Treatments Being Tested
This study will evaluate the impact of CYP3A4 induction on the single-dose ...
Status
Completed
Location
Alkermes Investigational Site
Start Date
2015-07
Trial ID
NCT02545439
Treatments Being Tested
This study will evaluate the impact of water consumption on the pharmacokin...
Status
Completed
Location
Alkermes Investigational Site
Start Date
2015-07
Trial ID
NCT02521857
Treatments Being Tested
This study will evaluate the efficacy and safety of ALKS 5461....
Status
Completed
Location
Alkermes Investigational Site
Start Date
2014-07
Trial ID
NCT02218008
This is a study to test the safety of ALKS 5461 in healthy adults....
Status
Completed
Location
Alkermes Investigational Site
Start Date
2014-01
Trial ID
NCT02068105
This is a multicenter, randomized, double-blind, placebo-controlled, parall...
Status
Completed
Location
Comprehensive NeuroScience, Inc.
Start Date
2011-05
Trial ID
NCT01381107
This study will evaluate the efficacy and safety of ALKS 5461....
Status
Completed
Location
Alkermes Investigational Site
Start Date
2014-05
Trial ID
NCT02158546
This study will assess the long-term safety and tolerability of ALKS 5461 a...
Status
Terminated
Location
Alkermes Investigational Site
Start Date
2018-08-09
Trial ID
NCT03610048
Treatments Being Tested